











10．CNS High-grade Neuroepithelial Tumor with BCOR 






【背景と目的】 CNS high-grade neuroepithelial tumors with 
BCOR alteration（CNS HGNET-BCOR）は，CNS primitive 
neuroectodermal tumor と診断された脳腫瘍に対する大規
模 DNA メチル化解析によって 2016 年に分離された稀な
腫瘍型である．同腫瘍は BCOR 遺伝子 3’末端における






BCOR に相当すると考えられる 6 例を収集し，FFPE 検体










BCOR 遺伝子 exon15 における ITD が全例に認められた．
【考察と結語】 CNS HGNET-BCOR は腎明細胞肉腫など
と共に BCOR ITD 陽性腫瘍の一部をなすが，形態学的・
免疫組織化学的にグリアへの分化が示唆され，腎や軟部の
肉腫とは異なる性質を有することが示された．
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【Background & Objective】 Gadolinium-based contrast 
agents (GBCAs) are particularly useful for detecting aggres-
sive or metastatic brain tumors and vascular lesions. How-
ever, recent studies demonstrated that the use of GBCAs, 
especially linear type, resulting in retained gadolinium (Gd) 
in various organs, including the brain. Therefore, we inves-
tigated the chemical structure of the retained Gd in various 
parts of the brain after intravenously administering a single 
injection of GBCAs in normal mouse.　【Methods】 Ten 
ddY mice were randomly divided into two groups to be 
injected with gadopentetate at a dose of 5 mmol╱kg while 5 
mice in the control group received 250 µL saline via the tail 
vein. Samples of olfactory bulb, cerebral cortex, cerebel-
lum, cerebrospinal fluid, and choroid plexus were collected at 
5 minutes (5m) and 10days (10d) after the injection. Pro-
teins was extracted and separated by chromatography, and Gd 
concentrations were quantified by mass spectrometry. 　
【Results】 Five minutes after the injection, CSF had the 
highest Gd concentration in the gadopentetate group (90.95＋
21.28 µg╱g), which was significantly higher than the brain 
tissue (13.02＋5.86 µg╱g; p＜0.01). Although Gd from 
gadopentetate was significantly decreased at 10d (p＜0.01), 
the retained Gd from gadopentetate (1.45＋0.71 µg╱g) was 
found in larger proteins than the contrast agent (＞
93 kDa). The exact complex and the Gd concentration from 
the insoluble pellet were not determined.　【Conclusion】
GBCA distribution into the brain is likely through the brain 
barrier and may be correlated with the chemical structures of 
the contrast agent. Gd from gadopentetate bound with larger 
